Eric Aliotta, PhD

Assistant Attending Physicist
Department of Medical Physics

Eric Aliotta, PhD

Assistant Attending Physicist
Share
Share
Eric Aliotta

Education

PhD, Biomedical Physics, University of California at Los Angeles

I am an assistant attending physicist in the Radiotherapy Physics Service of the Department of Medical Physics. I received my PhD in Biomedical Physics from the University of California at Los Angeles and completed a clinical physics residency at the University of Virginia in the Radiation Oncology Department.

My clinical and research interests are focused on the use of quantitative MRI biomarkers to improve cancer treatment. I am interested in developing noninvasive MRI techniques that can determine tumor genetics and inform other important tissue characteristics. I aim to incorporate these techniques into MR-guided radiotherapy workflows to improve our ability to plan and adapt treatments.

Disclosures

Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.

MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.

Eric Aliotta discloses the following relationships and financial interests:

  • University of California, Los Angeles (UCLA)
    Intellectual Property Rights

The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.


This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.

Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].


View all disclosures